O
PCRX icon

OppenheimerFunds’s Pacira BioSciences PCRX Stock Holding History

OppenheimerFunds’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-132,450
Closed -$10.2M – 1726
2015
Q4 		$10.2M Buy
+132,450
New +$7.5M 0.01% 737
2015
Q2 		– Sell
-117,000
Closed -$10.4M – 955
2015
Q1 		$10.4M Sell
117,000
-125,600
-52% -$12.7M 0.01% 744
2014
Q4 		$21.5M Sell
242,600
-79,430
-25% -$7.51M 0.02% 576
2014
Q3 		$31.2M Sell
322,030
-18,330
-5% -$1.78M 0.03% 460
2014
Q2 		$31.3M Buy
340,360
+17,120
+5% +$1.3M 0.03% 464
2014
Q1 		$22.6M Buy
+323,240
New +$22M 0.03% 544

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

OppenheimerFunds's PCRX Position: Q1 2016 in Review

OppenheimerFunds sold out of Pacira BioSciences (PCRX) in Q1 2016, closing a stake of 132,450 shares — an estimated $10.2M sold.

OppenheimerFunds first reported a position in PCRX in Q1 2014 and held it in 6 quarters. The position peaked at $31.3M in Q2 2014. 180 funds tracked by Wall St. Rank hold PCRX as of Q1 2016.

  • OppenheimerFunds reported no remaining Pacira BioSciences position as of Q1 2016 after selling out during the quarter.
  • OppenheimerFunds sold 132,450 Pacira BioSciences shares in Q1 2016, an estimated $10.2M.
  • OppenheimerFunds first reported a position in Pacira BioSciences in Q1 2014 and held it in 6 quarters.
  • OppenheimerFunds's Pacira BioSciences position peaked at $31.3M in Q2 2014.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2016.

Based on OppenheimerFunds's 13F filing for Q1 2016, filed 12 May 2016.